Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study.
Moreno DA, da Silva LS, Zanon MF, Bonatelli M, de Paula FE, de Medeiros Matsushita M, Teixeira GR, Santana IVV, Saggioro F, Neder L, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Garcia-Rivello H, Christiansen S, Nunes S, da Costa MJG, Soares MJ, Pinheiro J, Junior CA, Mançano BM, Reis RM. Moreno DA, et al. Among authors: reis rm. J Neurooncol. 2022 Mar;157(1):27-35. doi: 10.1007/s11060-022-03965-1. Epub 2022 Feb 15. J Neurooncol. 2022. PMID: 35166989
Analysis of microsatellite instability in medulloblastoma.
Viana-Pereira M, Almeida I, Sousa S, Mahler-Araújo B, Seruca R, Pimentel J, Reis RM. Viana-Pereira M, et al. Among authors: reis rm. Neuro Oncol. 2009 Oct;11(5):458-67. doi: 10.1215/15228517-2008-115. Epub 2009 Jan 29. Neuro Oncol. 2009. PMID: 19179424 Free PMC article.
The role of microRNAs in medulloblastoma.
Vidal DO, Marques MM, Lopes LF, Reis RM. Vidal DO, et al. Among authors: reis rm. Pediatr Hematol Oncol. 2013 Aug;30(5):367-78. doi: 10.3109/08880018.2013.783890. Epub 2013 Mar 25. Pediatr Hematol Oncol. 2013. PMID: 23528184 Review.
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J. Batista R, et al. Among authors: reis rm. Int J Cancer. 2016 Jul 15;139(2):414-23. doi: 10.1002/ijc.30057. Epub 2016 Mar 24. Int J Cancer. 2016. PMID: 26914704 Free article.
Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.
Silva-Oliveira RJ, Silva VA, Martinho O, Cruvinel-Carloni A, Melendez ME, Rosa MN, de Paula FE, de Souza Viana L, Carvalho AL, Reis RM. Silva-Oliveira RJ, et al. Among authors: reis rm. Cell Oncol (Dordr). 2016 Jun;39(3):253-63. doi: 10.1007/s13402-016-0270-z. Epub 2016 Feb 26. Cell Oncol (Dordr). 2016. PMID: 26920031
529 results